# The Next Disease X‐ H5N6 Avian Influenza's Evolving Threat to Human Health and Chances of Future Global Outbreak: A Narrative Review

## TL;DR

H5N6 avian influenza is a deadly virus with pandemic potential that requires global vigilance and preparedness.

## Contribution

This paper reviews H5N6's evolution, zoonotic potential, and public health risks to highlight the need for proactive measures.

## Key findings

- H5N6 has a high fatality rate and is evolving to infect mammals more effectively.
- The virus can bind to human respiratory cells, increasing future transmission risks.
- Stronger surveillance and biosecurity are critical to prevent a potential global outbreak.

## Abstract

H5N6 avian influenza has been a concern that can initiate the next global pandemic (called Disease X). Most infections have been among those in Asia, especially China, since the 2014 first human case. With a fatality rate of 61%, the virus is very deadly, even though the total number of human cases is relatively low. This paper aims to evaluate the epidemiological trends, genetic evolution, and zoonotic potential of H5N6, with a focus on its capacity to become a future pandemic agent.

This narrative review is based on a comprehensive synthesis of published literature, including peer‐reviewed epidemiological studies, genetic analyses and clinical case reports. Key themes examined include viral evolution, host adaptation, transmission patterns, and disease pathogenesis, with particular attention to the zoonotic potential and public health implications of H5N6.

Genetically, H5N6 is still evolving and is moreover becoming increasingly adept at infecting birds and mammals. The epidemiology of the virus, its genetic mutations, and its patterns of transmission are examined with emphasis on how the virus can cross from animals to humans. H5N6, however, has demonstrated the capacity to bind to human respiratory cells, making this a potentially more likely vector of human‐to‐human transmission in the future. The virus is evolving, however, and while sustained transmission between people has not yet taken place, the developing risk is expanding.

The only thing that should help here is that global health systems must be more vigilant by adding stronger bio‐security measures, more surveillance, and more common efforts toward vaccine research. The spread of H5N6 in both domestic and wild populations also means that a perpetually high level of monitoring, especially in high‐risk areas such as live poultry markets, is necessary. H5N6 could evolve to become a serious public health threat and this paper highlights the urgent need for preparedness.